Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.4 - $0.91 $4,569 - $10,395
11,424 Added 9.04%
137,747 $73,000
Q4 2023

Feb 14, 2024

BUY
$0.71 - $0.97 $6,152 - $8,405
8,665 Added 7.36%
126,323 $114,000
Q3 2023

Nov 09, 2023

BUY
$0.96 - $2.01 $27,074 - $56,688
28,203 Added 31.53%
117,658 $115,000
Q2 2023

Aug 14, 2023

SELL
$1.59 - $2.29 $117,233 - $168,846
-73,732 Reduced 45.18%
89,455 $156,000
Q1 2023

May 15, 2023

BUY
$2.05 - $2.87 $50,097 - $70,137
24,438 Added 17.61%
163,187 $372,000
Q4 2022

Feb 13, 2023

BUY
$2.06 - $3.47 $29,392 - $49,509
14,268 Added 11.46%
138,749 $299,000
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.12 $105,614 - $207,979
40,621 Added 48.44%
124,481 $356,000
Q2 2022

Aug 11, 2022

BUY
$2.19 - $3.98 $183,653 - $333,762
83,860 New
83,860 $208,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $992M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.